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Introduction: The Epstein-Barr virus was found in 1968 as the major cause of infectious 
mononucleosis. Since then the diagnosis of EBV has gone a way from the nonspecific tests, such as the 
heterophile antibody test, to specific EBV antibody tests performed through IFA, the “gold standard”, 
different immunoassay techniques, additional tests, used for confirmation such as avidity test and 
Western blot, to PCR, mainly used in patient with immunosuppression. The seroprevalence in adult 
population is wide, ranging from 85% in developed counties to 95-100% in developing counties. By age 
5 seroprevalence in the UK and USA is 50%. In RM the incidence of mononucleosis has increased from 
0.97 in 1992, to 2.97 in 2007. Although laboratory diagnosis in mononucleosis is straightforward and 
available, it still imposes some questions, due to high variability of EBV serology.
The objective of this research is to study and discuss the challenges of laboratory diagnosis and 
staging of EBV infection based on serological profiles of the patients tested to EBV infection at the 
Hospital for Infectious Diseases in Children, in Chisinau, R. of Moldova during the year 2015. 
Materials and methods: the materials used are blood serum or plasma samples from 311 patients 
from 5 months old to 17 years old from the Hospital for Infectious Diseases in Children, who were 
consulted or admitted with suspected mononucleosis or hepatitis of unknown origin. Blood was tested 
to EBV-CA IgM and IgG, EA IgG, EBNA -1 IgG, anti CMV IgM and IgG, anti HAV IgM. The testing 
system used is the enzyme immunoassay. The interpretation of the results given by reagent 
manufacturers is: 1) Primary infection VCA IgM positive, VCA IgG pos/neg, EA IgG pos/neg, EBNA 
IgG negative, 2)Past infection VCA IgM negative, VCA IgG and EBNA IgG positive, 3)Reactivation 
VCA IgM, VCA IgG, EBNA IgG positive.
Patients are categorized by their serology profile (VCA IgM and IgG, EBNA-1 IgG) in 3 main 
groups, patients with serology characteristic to acute infection, past infection, and patients with serology 
that can be interpreted either way.
Discussion results: 209 blood samples were found positive to at least 1 marker of EBV infection. 
114 had VCA IgM negative, VCA IgG and EBNA IgG positive. 34 were VCA IgM and IgG positive 
and EBNA IgG negative. 12 were VCA IgG positive VCA IgM and EBNA IgG negative, 25 were VCA 
IgG and IgM positive, EBNA IgG positive, 19 were VCA IgM positive, VCA IgG and EBNA IgG 
negative, and 4 were only EA IgG or EBNA IgG positive. 
Conclusion: 67.2% of samples were positive to EBV infection, which meant primary or past 
infection, 65.8% being children under age of 6 years. From them 54.5% had a serological pattern of past 
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infection, 25.3% had indicators of primary infection, the rest (19.6%) had serological patterns that might 
have benefit from additional tests, such as avidity tests, western blot or PCR.
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Introduction: Neuroplasticity refers to the potential that the brain has to reorganize by creating 
new neural pathways to adapt, as it needs. Think of the neurological changes being made in the brain as 
the brain's way of tuning itself to meet your needs. The more you focus and practice something the better 
you become at the new skill that you are learning or an obstacle you are trying to overcome. By doing 
this new neural connections are created in the brain as synapses that don't usually fire together do, which 
help us to sharpen our new skill.
Materials and methods: Motor symptoms are common and disabling across the phases and 
forms of multiple sclerosis. Disease modifying treatments help to prevent their development, but most 
of their management is through rehabilitation. Current rehabilitation approaches are based on physical 
therapy tailored to the individual’s needs. The efficacy of these approaches, however, is limited, as it is 
purely based on clinical grounds, and is largely unpredictable in the individual case, where several 
factors, including location, extent, and severity of multiple sclerosis damage, can contribute to individual 
variation in rehabilitation outcomes. Therefore, an improved understanding of the neural processes 
underlying functional recovery and driven by rehabilitation, as well as the development of novel 
recovery interventions that fully exploit the individual patient’s potential to recover motor function 
remain a clinical necessity and a research priority.
Discussion results: Rehabilitation of the damaged brain can foster reconnection of damaged 
neural circuits in multiple sclerosis. Learning mechanisms play an important part in this. We studied a 
triage of post-lesion states, depending on the loss of connectivity in particular circuits. A small loss of 
connectivity will tend to lead to autonomous recovery, whereas a major loss of connectivity will lead to 
permanent loss of function; for such individuals, a compensatory approach to recovery is required. 
Empirical data are implemented in a neural network model, and clinical recommendations for the 
practice of rehabilitation following brain damage are made.
Conclusion: Cortical reorganization has been demonstrated in the motor network that mediates 
performance of a motor task in patients with multiple sclerosis. Rehabilitation of motor function is a 
major component of management that is supported by neuroplasticity, the brain’s ability to adapt to 
multiple sclerosis damage or disability. The need for novel rehabilitation approaches, underpinned by 
promoted and enhanced neuroplasticity, challenges traditional experimental designs. This challenge can 
be addressed using methodological advances, especially in neuroimaging, which allow improved 
understanding of mechanisms and detection of intervention effects.
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